173 related articles for article (PubMed ID: 19272817)
1. Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sklavounou A; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):837-43. PubMed ID: 19272817
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of the mTOR pathway in intra-oral minor salivary gland neoplasms.
Diamanti S; Nikitakis N; Rassidakis G; Doulis I; Sklavounou A
Oral Dis; 2016 Oct; 22(7):620-9. PubMed ID: 27177463
[TBL] [Abstract][Full Text] [Related]
4. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
5. RANK and RANKL Expression in Salivary Gland Tumors.
Aslan F; Küçük Ü
Ear Nose Throat J; 2020 Aug; 99(7):475-480. PubMed ID: 32525717
[TBL] [Abstract][Full Text] [Related]
6. Immunoprofile of c-MET/PI3K signaling in human salivary gland tumors.
Vasconcelos AC; Wagner VP; Meurer L; Vargas PA; de Souza LB; Fonseca FP; Squarize CH; Castilho RM; Martins MD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Aug; 120(2):238-47. PubMed ID: 26117810
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of oestrogen receptor-α and progesterone receptor in salivary gland tumours.
Kolude B; Adisa A; Adeyemi B; Lawal A
J Oral Pathol Med; 2013 Oct; 42(9):716-9. PubMed ID: 23601083
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors.
Aoyama T; Takasawa A; Murata M; Osanai M; Takano K; Hasagawa T; Sawada N
Med Mol Morphol; 2019 Mar; 52(1):23-35. PubMed ID: 29955965
[TBL] [Abstract][Full Text] [Related]
9. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
[TBL] [Abstract][Full Text] [Related]
10. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
[TBL] [Abstract][Full Text] [Related]
11. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
12. Reduced chromatin acetylation of malignant salivary gland tumors correlates with enhanced proliferation.
Wagner VP; Martins MD; Guimaraes DM; Vasconcelos AC; Meurer L; Vargas PA; Fonseca FP; Squarize CH; Castilho RM
J Oral Pathol Med; 2017 Oct; 46(9):792-797. PubMed ID: 28161900
[TBL] [Abstract][Full Text] [Related]
13. Salivary Gland Tumors: A Clinicopathologic Analysis From Taipei Veterans General Hospital.
Liao WC; Chih-Chao C; Ma H; Hsu CY
Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S26-S33. PubMed ID: 31833885
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation.
Kim KW; Mutter RW; Cao C; Albert JM; Shinohara ET; Sekhar KR; Lu B
Mol Cancer Ther; 2006 Nov; 5(11):2659-65. PubMed ID: 17121912
[TBL] [Abstract][Full Text] [Related]
15. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin.
Peroukides S; Bravou V; Alexopoulos A; Varakis J; Kalofonos H; Papadaki H
Histol Histopathol; 2010 Mar; 25(3):299-307. PubMed ID: 20054802
[TBL] [Abstract][Full Text] [Related]
16. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.
Can NT; Lingen MW; Mashek H; McElherne J; Briese R; Fitzpatrick C; van Zante A; Cipriani NA
Head Neck Pathol; 2018 Mar; 12(1):95-104. PubMed ID: 28681314
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland tumors at in vivo proton MR spectroscopy.
King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
[TBL] [Abstract][Full Text] [Related]
18. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
Diaz N; Minton S; Cox C; Bowman T; Gritsko T; Garcia R; Eweis I; Wloch M; Livingston S; Seijo E; Cantor A; Lee JH; Beam CA; Sullivan D; Jove R; Muro-Cacho CA
Clin Cancer Res; 2006 Jan; 12(1):20-8. PubMed ID: 16397019
[TBL] [Abstract][Full Text] [Related]
19. An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers.
Wang B; Gan J; Liu Z; Hui Z; Wei J; Gu X; Mu Y; Zang G
J Exp Clin Cancer Res; 2022 Dec; 41(1):350. PubMed ID: 36527158
[TBL] [Abstract][Full Text] [Related]
20. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
Li J; Piao YF; Jiang Z; Chen L; Sun HB
World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
